These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18221172)

  • 21. Synthesis and antibacterial activity of new 7-piperazinyl-quinolones containing a functionalized 2-(furan-3-yl)ethyl moiety.
    Foroumadi A; Mohammadhosseini N; Emami S; Letafat B; Faramarzi MA; Samadi N; Shafiee A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):47-52. PubMed ID: 17206610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinolones and Fluoroquinolones to Treat Salmonella Typhimurium: A Review of Metabolism and Pharmacokinetics.
    Balasundaram P; Veerappapillai S; Karuppasamy R
    Curr Drug Metab; 2017; 18(12):1085-1094. PubMed ID: 28699507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action.
    Hubschwerlen C; Specklin JL; Baeschlin DK; Borer Y; Haefeli S; Sigwalt C; Schroeder S; Locher HH
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4229-33. PubMed ID: 14623007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety issues and drug-drug interactions with commonly used quinolones.
    Douros A; Grabowski K; Stahlmann R
    Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):25-39. PubMed ID: 25423877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antibacterial activity of new N-[2-(thiophen-3-yl)ethyl] piperazinyl quinolones.
    Letafat B; Emami S; Mohammadhosseini N; Faramarzi MA; Samadi N; Shafiee A; Foroumadi A
    Chem Pharm Bull (Tokyo); 2007 Jun; 55(6):894-8. PubMed ID: 17541188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibacterial activity of quinolones against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory].
    Nakamura T; Shimizu C; Hirakawa K; Inui S; Okuda K; Nakata C; Fujimoto H; Okura H; Uemura Y; Takahashi H
    Jpn J Antibiot; 2009 Jun; 62(3):194-202. PubMed ID: 19882980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bactericidal activity of sitafloxacin and other new quinolones against antimicrobial resistant Streptococcus pneumoniae].
    Kobayashi I; Kanayama A; Hasegawa M; Kaneko A
    Jpn J Antibiot; 2013 Feb; 66(1):25-35. PubMed ID: 23777014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
    Qiu H; Gong J; Butaye P; Lu G; Huang K; Zhu G; Zhang J; Hathcock T; Cheng D; Wang C
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29767711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis and Molecular Docking of 1-Cyclopropyl-6- Fluoro-4-Oxo-7-{4-[2-(4-Substituted-Phenyl)-2-(Substituted)-Ethyl] -1-Piperazinyl}-1,4-Dihydroquinoline-3-Carboxylic Acid as an Antimicrobial Agents.
    Patel MM; Patel LJ
    Curr Drug Discov Technol; 2017; 14(4):255-269. PubMed ID: 28240185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quinolone antibacterial agents. Synthesis and structure-activity relationships of a series of amino acid prodrugs of racemic and chiral 7-(3-amino-1-pyrrolidinyl)quinolones. Highly soluble quinolone prodrugs with in vivo pseudomonas activity.
    Sanchez JP; Domagala JM; Heifetz CL; Priebe SR; Sesnie JA; Trehan AK
    J Med Chem; 1992 May; 35(10):1764-73. PubMed ID: 1366133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antibacterial activities of new quinolone derivatives utilizing 1-azabicyclo[1.1.0]butane.
    Ikee Y; Hashimoto K; Nakashima M; Hayashi K; Sano S; Shiro M; Nagao Y
    Bioorg Med Chem Lett; 2007 Feb; 17(4):942-5. PubMed ID: 17157008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity.
    Naeem A; Badshah SL; Muska M; Ahmad N; Khan K
    Molecules; 2016 Mar; 21(4):268. PubMed ID: 27043501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insight into Prodrugs of Quinolones and Fluoroquinolones.
    Sharma PC; Piplani M; Mittal M; Pahwa R
    Infect Disord Drug Targets; 2016; 16(3):140-161. PubMed ID: 27558786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Basis of quinolone antibiotics].
    Mitsuyama J
    Nihon Yakurigaku Zasshi; 2007 Oct; 130(4):287-93. PubMed ID: 17938514
    [No Abstract]   [Full Text] [Related]  

  • 35. The quinolone family: from antibacterial to anticancer agents.
    Sissi C; Palumbo M
    Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):439-50. PubMed ID: 14529452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.
    Changkwanyeun R; Yamaguchi T; Kongsoi S; Changkaew K; Yokoyama K; Kim H; Suthienkul O; Usui M; Tamura Y; Nakajima C; Suzuki Y
    Drug Test Anal; 2016 Oct; 8(10):1071-1076. PubMed ID: 26857529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmid-mediated quinolone resistance--current knowledge and future perspectives.
    Guan X; Xue X; Liu Y; Wang J; Wang Y; Wang J; Wang K; Jiang H; Zhang L; Yang B; Wang N; Pan L
    J Int Med Res; 2013 Feb; 41(1):20-30. PubMed ID: 23569126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and study of 1-ethyl-3-carbohydrazide and 3-[1-oxo-2-hydrazino-3-{p-toluenesulfon}]quinolone derivatives against bacterial infections.
    Srivastava N; Kumar A
    Eur J Med Chem; 2013 Sep; 67():464-8. PubMed ID: 23933534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quinolones. Nowadays perspectives and mechanisms of resistance].
    Álvarez-Hernández DA; Garza-Mayén GS; Vázquez-López R
    Rev Chilena Infectol; 2015 Oct; 32(5):499-504. PubMed ID: 26633105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 7-Azetidinylquinolones as antibacterial agents. 3. Synthesis, properties and structure-activity relationships of the stereoisomers containing a 7-(3-amino-2-methyl-1-azetidinyl) moiety.
    Frigola J; Vañó D; Torrens A; Gómez-Gomar A; Ortega E; García-Granda S
    J Med Chem; 1995 Mar; 38(7):1203-15. PubMed ID: 7707323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.